All blog articles
Dexcom CGM Explained

Dexcom G7 is now compatible with the Tandem t:slim X2™ insulin pump with Control-IQ Technology


Oct. 17, 2024 5 min read

Man Sitting Down showing Product





Get started on Dexcom G7

If you are living with diabetes and not using CGM, talk to your doctor about Dexcom CGM and AID options. We can help you get started with a free benefits check. Click the button below to send us some basic information.
  • Start on Dexcom CGM Today

*Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings. †Dexcom G7 can complete warmup within 30 minutes, whereas other CGM brands require up to an hour or longer. ‡Audible and visual notification of predictive alert at 55mg/dl within 20 minutes. §Separate Follow app and internet connection required. ||Bolus delivery from the t:connect mobile app requires a compatible smartphone model and operating system, an app update, a remote software update on the customer’s t:slim X2 insulin pump and additional training. Only available to Tandem Diabetes Care customers who reside in the United States. ¶Dexcom G7 can complete warmup within 30 minutes, whereas other CGM brands require up to an hour or longer.
1 Brown SA, et al. N Engl J Med. 2019;381(18):1707-1717. 2 Brown SA, et al. Diabetes Care. 2021;44(7):1630-1640. 3 Russell SJ, et al. N Engl J Med. 2022;387(13):1161-1172. 4 Understanding Automated Insulin Delivery (AID) Systems. Association of Diabetes Care & Education Specialists; 2022. Available at: https:/www.diabeteseducator.org/docs/default-source/dana-files/insulin_delivery_systems2_aid(1)4d90eaea-9dcc-4b0a-9ec0-3b1fa9dca575.pdf?sfvrsn=2ab06b59_3. Accessed October 6, 2023. 5 Lewis, D.M., Hussain, S. Practical Guidance on Open Source and Commercial Automated Insulin Delivery Systems: A Guide for Healthcare Professionals Supporting People with Insulin-Requiring Diabetes. Diabetes Ther 13, 1683–1699 (2022). https://doi.org/10.1007/s13300-022-01299-9 Diabetes Ther (2022) 13:1683–1699 6 Peacock S, et al. Diabetes Ther. 2023;14(5):839-855.
BRIEF SAFETY STATEMENT: Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safetyinformation and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.
RX ONLY. The t:slim X2 insulin pump with Control-IQ technology is indicated for patients with type 1 diabetes, 6 years and older. BOXED WARNING: Control-IQ technology should not be used by people under age 6, or who use less than 10 units of insulin/day, or who weigh less than 55 lbs. For full safety information, visit tandemdiabetes.com/safetyinfo.
Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved.
Tandem Diabetes Care, the Tandem logo, Control-IQ, and t:slim X2 are either registered trademarks or trademarks of Tandem Diabetes Care, Inc. in the United States and/or other countries

Related articles

View all
Privacy PolicyTerms of Use

LBL-1001419 Rev008

MAT-0775

© Dexcom, Inc. All rights reserved.

US flag

US